Reaction
Hyperviscosity Syndrome reporting signals
As of the last recalculation, Hyperviscosity Syndrome appears in 286 FAERS reports alongside 3 co-occurring drug terms. The strongest observed disproportionality signal is BORTEZOMIB (PRR 66.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Bortezomib | 64 | 66.8 | 66.9 |
| Bendamustine Hcl | 8 | 38.6 | 38.6 |
| Carfilzomib | 14 | 37.8 | 37.8 |